By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

MD Anderson Cancer Center 

500 Renaissance Drive

St. Joseph  Michigan  49085  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
MD Anderson Cancer Center And PPRI In Early Stage Breast Cancer Studies With IncellDx, Inc. Oncobreast3Dx® Technology 1/27/2015 8:05:35 AM
MD Anderson Cancer Center to Earn $100 Million From Intrexon Corporation and ZIOPHARM Oncology, Inc. (ZIOP.OB) for Immunotherapy Game-changer 1/14/2015 7:04:31 AM
Amgen (AMGN) And MD Anderson Cancer Center Announce Agreement To Develop Bite® Therapies For Myelodysplastic Syndrome 1/13/2015 6:59:55 AM
Boston Strategics Corporation Enters Into An Innovative Risk-Sharing Agreement With MD Anderson Cancer Center To Conduct A Phase 1/2a Clinical Trial Of E6201 In Patients With Advanced Hematologic Malignancies Including Acute Myeloid Leukemia 12/17/2014 11:40:20 AM
MD Anderson Cancer Center Officials React To FDA Approval Of Gardasil 9 For The Prevention Of Certain Cancers 12/12/2014 8:13:52 AM
Manhattan Scientifics, Inc.’ Unparalleled Cancer Measurement Technology Featured In MD Anderson Cancer Center Presentation 10/8/2014 7:50:01 AM
Biocept, Inc. (BIOC) Expands Collaboration With MD Anderson Cancer Center 10/7/2014 7:51:08 AM
Bristol-Myers Squibb Company (BMY) And MD Anderson Cancer Center Announce Novel Research Collaboration In Immuno-Oncology Focused On Leukemia And Hematologic Malignancies 10/6/2014 8:24:14 AM
VolitionRX Announces Prostate Cancer Collaboration With The University of Texas MD Anderson Cancer Center 10/2/2014 9:10:57 AM
MD Anderson Cancer Center Department Chair Richard E. Champlin, M.D. Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab™-B Scientific Advisory Board 9/10/2014 10:10:54 AM
1234567
//-->